CGC
Canopy Growth Corporation
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$0.97
−0.02%Margins
Gross margin
25.5%
EBITDA margin
-58.6%
EBIT margin
-31.9%
Net margin
-80.7%
FCF margin
-26.0%
-37.6%
Return on equity
-23.5%
Return on assets
-10.6%
Return on invested capital
0.29x
Asset turnover
-$56.9M
Cash from operations
$0.59
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026